Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum
Yong-lin Lu, Ya-bin Ma, Chan Feng, Dong-lei Zhu, Jie Liu, Lv Chen, Shu-jing Liang, Chun-yan Dong
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoparticle-Based Drug Delivery · Monoclonal and Polyclonal Antibodies Research · RNA Interference and Gene Delivery
The original version of this article contained errors in Figure 7B. Specifically, three HE-stained images were incorrectly used; two images (heart and spleen) are from the DOX group, while one image (heart) is from the CYC+DOX group. These errors have now been corrected. All other images in the figure remain unchanged, and the interpretation of the results is unaffected. The authors apologize for any inconvenience this may have caused. The correct images appear below.